Tech Company Financing Transactions
Aspect Biosystems Funding Round
Aspect Biosystems, based in Vancouver BC, raised $115 million from Dimension, InBC Investment and JDRF T1D Fund.
Transaction Overview
Company Name
Announced On
1/9/2025
Transaction Type
Venture Equity
Amount
$115,000,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to advance multiple bioprinted tissue therapeutics towards the clinic with a mission to deliver a new class of cellular medicines and functional cures for people living with serious metabolic and endocrine diseases.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1781 West 75th Ave.
Vancouver BC, V6P 6P2
Canada
Vancouver BC, V6P 6P2
Canada
Phone
Website
Email Address
Overview
We are innovating at the intersection of biology, medicine, and engineering to build living human tissues.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Tamer Mohamed
Chief Financial Officer
Michael Liggett
Chief Scientific Officer
Sam Wadsworth
Chief Technical Officer
Simon Beyer
VP - Engineering
Spiro Getsios
VP - Human Resources
Sandra Keyton
VP - Operations
Bojana Turic
VP - Sales
Stephanie Camacho
Browse more venture capital transactions:
Prev: 1/9/2025: Gridware venture capital transaction
Next: 1/9/2025: Epirus venture capital transaction
Share this article
Where The Data Comes From
We do our best to record funding rounds that are announced publicly. VC transactions reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs